(Q35993734)

11 August 2017

Reversal of adriamycin resistance by lonidamine in a human breast cancer cell line (English)

1 reference

11 August 2017

1 reference

1 reference

Citro G

1

1 reference

11 August 2017

Cucco C

series ordinal

2

1 reference

11 August 2017

Verdina A

series ordinal

3

1 reference

11 August 2017

Zupi G

series ordinal

4

1 reference

11 August 2017

language of work or name

English

0 references

publication date

1 September 1991

1 reference

British Journal of Cancer

11 August 2017

1 reference

11 August 2017

64

1 reference

11 August 2017

3

1 reference

11 August 2017

534-536

1 reference

https://scigraph.springernature.com/pub.10.1038/bjc.1991.345

11 August 2017

0 references

cites work

Phase II study of lonidamine in metastatic breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977636

Mechanism of multidrug resistance

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977636

Modulation of glycolysis in neuroepithelial tumors

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977636

A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977636

In vitro and in vivo potentiation by lonidamine of the antitumor effect of adriamycin.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977636

Isolation of amplified and overexpressed DNA sequences from adriamycin-resistant human breast cancer cells.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977636

Effects of 2-deoxyglucose on drug-sensitive and drug-resistant human breast cancer cells: toxicity and magnetic resonance spectroscopy studies of metabolism.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977636

Lonidamine can enhance the cytotoxic effect of cisplatin in human tumour cells and rodent cells.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977636

Drug resistance in cancer

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977636

On the mechanism of action of lonidamine: a study on human erythrocyte membrane

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1977636

Glucose metabolism in drug-sensitive and drug-resistant human breast cancer cells monitored by magnetic resonance spectroscopy

23 September 2018

1 reference

12 December 2020

1 reference

12 December 2020

Quantitation of adriamycin content by a sensitive immunochemical assay

1 reference

12 December 2020

Phase II evaluation of Lonidamine in patients with advanced malignancy

1 reference

12 December 2020

Treatment of poor prognosis nonseminomatous testicular cancer with a "high-dose" platinum combination chemotherapy regimen

1 reference

12 December 2020

Action of the antitumor and antispermatogenic agent lonidamine on electron transport in ehrlich ascites tumor mitochondria

1 reference

12 December 2020

Radiosensitization of Meth-A fibrosarcoma in mice by Lonidamine

1 reference

12 December 2020

Identifiers

DOI

10.1038/BJC.1991.345

1 reference

11 August 2017

1 reference

11 August 2017

1 reference